Current filters:

Botulinum Toxin Type A

1 to 9 of 65 results

Espicom views Allergan’s performance, products, pipeline and potential


Allergan, with headquarters in Irvine, California, USA, is a global specialty pharmaceutical company…

AllerganBotoxBotulinum Toxin Type ABotulinum Toxin Type BMyoblocNorth AmericaPharmaceutical

FDA asks for more info on new Botox indication


The US Food and Drug Administration has delayed approving Allergan's Botox (botulinum toxin type A) for…

Abobotulinumtoxin A InjectionAllerganBotoxBotulinum Toxin Type ADysportIpsen

Stock Commentary - Europe - week to April 27, 2009


EUROPEAN: bourses were mostly significantly higher over the reporting week to April 27, with STOCKHOLM…

AvastinAventis PharmabevacizumabBotoxBotulinum Toxin Type AGenentechGlaxoSmithKlineGSKIpsenRocheSanofi-Aventis

Stock Commentary - Europe - week to April 20, 2009


EUROPEAN: bourses headed higher for most of the reporting week to April 20, but plunged on the last day,…

AstraZenecaAventis PharmaBotoxBotulinum Toxin Type AGlaxoSmithKlineGSKIpsenNovartisRocheSanofi-AventisSolvay

Ipsen and Medicis are in talks to resolve delays to US approval of Reloxin


French drugmaker Ipsen and US partner Medicis are in talks with the Food and Drug Administration to resolve…

BotoxBotulinum Toxin Type AIpsen

1 to 9 of 65 results

Back to top